Literature DB >> 2387708

Mycobacterium avium-intracellulare in clinical specimens: etiological factor or contaminant?

A Lavy1, R Rusu, S Shaheen.   

Abstract

The Mycobacterium avium-intracellulare (MAI) group comprised 10.5% of all nontuberculous mycobacteria isolated in the Mycobacterium Reference Laboratory, Tel Aviv, in an 11-year study period. From the Buirej Chest Hospital in Gaza, alone, 273 strains were isolated, representing 12.1% of the specimens from that hospital, while 149 strains (0.24% of all specimens) were isolated from all other institutions. Pulmonary disease was attributed to this organism in 22 patients, 17 of whom were hospitalized (initially for tuberculosis or another lung disease) in Buirej Hospital. The water was thought to be the source of contamination, since MAI strains, similar to those found in sputum, were isolated from it. In 1985, the water system was renovated and the MAI incidence in sputum from this hospital consequently declined.

Entities:  

Mesh:

Year:  1990        PMID: 2387708

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  4 in total

Review 1.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

Review 2.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Mycobacterium simiae disseminated infection in a patient with acquired immunodeficiency syndrome.

Authors:  B Vandercam; J Gala; B Vandeweghe; J Degraux; G Wauters; L Larsson; A Bourlond; F Portaels
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

4.  Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients.

Authors:  M B Coyle; L C Carlson; C K Wallis; R B Leonard; V A Raisys; J O Kilburn; M Samadpour; E C Böttger
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.